Studies have shown that clinically relevant risk factors for refractory Mycoplasma pneumoniae pneumonia are extrapulmonary complications, large area lung morphogenesis, and elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH) levels (10, 11). This evidence concerns the gene CRP and Mycoplasma pneumoniae pneumonia.